Postmastectomy implant breast reconstruction is typically accomplished in a two-stage process involving a tissue expander that is later exchanged for a permanent implant. Adoption of an immediate one stage reconstruction (1-stage) approach, where feasible, has been slowed by surgeon perception that this method is less likely to achieve acceptable results.
To compare outcomes of these approaches in actual practice, we obtained commercial insurance claims on 1,316 patients throughout the United States who had immediate 1-stage or tissue expander (TE) postmastectomy implant breast reconstructions in 2008, without flaps, and compared results of these two reconstructive approaches over 18 months in terms of patient complication rates and return visits for additional procedures and/or treatment of complications.
Immediate 1-stage reconstructions were identified in 95 patients (7.2 percent), mean age 49.3 years, while 1,221 (92.8 percent), mean age 49.1 years, had TE reconstructions. Data shows a modest, non-significant trend toward fewer return visits after 1-stage reconstructions vs. TE reconstructions (191 vs. 242/100 patients, respectively); RR 0.95, NS. Complications of the implant, graft or mesh were the most common complication, experienced by 28.4 percent of 1-stage and 27.4 percent of TE reconstruction patients (RR 1.03, NS). Complications involving skin or connective tissue were also common, occurring in 20.0 percent of 1-stage and 26.4 percent of TE reconstruction patients (RR 0.76, NS). The average time to expander exchange was 189 days in patients without radiation and 288 days among irradiated patients.
The results show that surgeons in the United States achieved substantially similar results in immediate postmastectomy implant breast reconstructions with 1-stage and TE approaches in terms of patient complications and returns for reconstruction-related services over 18 months. As evolving mastectomy techniques make 1-stage implant reconstructions more attractive, we hope these findings will motivate researchers to compare the approaches in more strictly controlled clinical studies.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Cancer Trends Progress Report – 2009/2010 Update, National Cancer Institute, U.S. National Institutes of Health, DHHS, Bethesda, MD, April 2010, http://progressreport.cancer.gov; [accessibility confirmed 08.08.11]
- Cancer facts & figures 2010.American Cancer Society, Atlanta2010
- Statistics obtained from a survey of member plastic surgeons.2010
- Medium-term cost analysis of breast reconstructions in a single Dutch centre: a comparison of implants, implants preceded by tissue expansion, LD transpositions and DIEP flaps.J Plas Reconstruct Aesthet Surg. 2011; 64: 1043-1055
- Advances in nipple-sparing mastectomy: oncological safety and incision selection.Aesthet Surg J. 2011; 31: 310-319
- Nipple-sparing mastectomy update: 149 procedures and clinical outcomes.Arch Surg. 2008; 143: 1106-1110
- Breast reconstruction options following mastectomy.Cleve Clin J Med. 2008 Mar; 75: S17-S23
Published online: February 20, 2012
Accepted: December 21, 2011
Received: October 15, 2011
© 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.